Are people at risk from drinking milk from cows infected with H5N1 bird flu? And answers to other questions about the cattle outbreak.

April 3, 2024 Check out STAT+

Sponsored By

Darko Vojinovic/AP What we know about H5N1 bird flu in cows — and the risk to humans The situation is evolving, but here are some questions we can answer now about the curious case of H5N1 avian influenza in dairy cattle. By Helen Branswell STAT+ | Early data from rare-disease trial put spotlight on Moderna's efforts to turn mRNA into medicines The trial is being followed as a barometer for broader efforts to use mRNA — the pandemic hero — as a therapy, not a vaccine. By Andrew Joseph STAT+ | As AI proliferates, biopharma companies seek to harness it in clinical trials The concept is particularly appealing in oncology, where new medications that focus on smaller subsets of patients can make it difficult to enroll trials. By Allison DeAngelis Adobe Opinion: I saw the promise of diversity efforts in health care. A moment later I saw its critical gaps DEI helps transcend barriers between patients and doctors. Republican efforts to undo diversity will make bridging biases in medicine still harder. By David Velasquez STAT+ | FDA approves TriClip for tricuspid heart valve disease, pitting Abbott against Edwards Abbott's new device, TriClip, addresses tricuspid regurgitation where blood leaks backward through the tricuspid heart valve. By Lizzy Lawrence STAT+ | Genmab to buy ProfoundBio for $1.8 billion, the latest deal focused on targeted chemotherapies The $1.8 billion deal is the latest acquisition centered on antibody-drug conjugates, which deliver chemotherapies directly to tumor sites. By Andrew Joseph Adobe Opinion: Medicare coverage of weight loss drugs could save the U.S. billions of dollars The newest weight loss drugs are expensive. But their broader use could save the U.S. billions of dollars in health care costs. By Dana P. Goldman and Alison Sexton Ward

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser